abstract |
The present invention provides compounds of formula I wherein the variables are defined above and are useful for the treatment of therapeutic agents, particularly cancer. Of MDM2 inhibitor compounds. The present invention also relates to a pharmaceutical composition comprising an MDM2 inhibitor. |